Revised device labeling for the Cepheid Xpert MTB/RIF assay for detecting Mycobacterium tuberculosis
- PMID: 25719683
- PMCID: PMC5779596
Revised device labeling for the Cepheid Xpert MTB/RIF assay for detecting Mycobacterium tuberculosis
Abstract
The Food and Drug Administration (FDA) has cleared the Xpert MTB/RIF Assay (Cepheid; Sunnyvale, California) with an expanded intended use that includes testing of either one or two sputum specimens as an alternative to examination of serial acid-fast stained sputum smears to aid in the decision of whether continued airborne infection isolation (AII) is warranted for patients with suspected pulmonary tuberculosis. This change reflects the outcome of a recent multicenter international study demonstrating that negative Xpert MTB/RIF Assay results from either one or two sputum specimens are highly predictive of the results of two or three negative acid-fast sputum smears.
References
-
- Cepheid. Xpert MTB/RIF assay [package insert] Sunnyvale, CA: Cepheid; 2015. Available at http://www.cepheid.com/mtbrif-pi.
MeSH terms
LinkOut - more resources
Full Text Sources